Hyaluronic Acid Scaffolds for Loco-Regional Therapy in Nervous System Related Disorders

Int J Mol Sci. 2022 Oct 12;23(20):12174. doi: 10.3390/ijms232012174.

Abstract

Hyaluronic acid (HA) is a Glycosaminoglycan made of disaccharide units containing N-acetyl-D-glucosamine and glucuronic acid. Its molecular mass can reach 10 MDa and its physiological properties depend on its polymeric property, polyelectrolyte feature and viscous nature. HA is a ubiquitous compound found in almost all biological tissues and fluids. So far, HA grades are produced by biotechnology processes, while in the human organism it is a major component of the extracellular matrix (ECM) in brain tissue, synovial fluid, vitreous humor, cartilage and skin. Indeed, HA is capable of forming hydrogels, polymer crosslinked networks that are very hygroscopic. Based on these considerations, we propose an overview of HA-based scaffolds developed for brain cancer treatment, central and peripheral nervous systems, discuss their relevance and identify the most successful developed systems.

Keywords: hyaluronic acid; hydrogels; nervous system; scaffolds.

Publication types

  • Review

MeSH terms

  • Acetylglucosamine*
  • Disaccharides
  • Glucuronic Acid
  • Glycosaminoglycans
  • Humans
  • Hyaluronic Acid*
  • Hydrogels
  • Nervous System
  • Polyelectrolytes
  • Tissue Engineering
  • Tissue Scaffolds

Substances

  • Hyaluronic Acid
  • Polyelectrolytes
  • Acetylglucosamine
  • Hydrogels
  • Glycosaminoglycans
  • Glucuronic Acid
  • Disaccharides